{"id":"W3163731137","doi":"10.1016/j.euo.2021.04.008","title":"Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503)","year":2021,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Docetaxel; Clinical endpoint; Prostate cancer; Hazard ratio; Androgen deprivation therapy; Population; Prostatectomy; Internal medicine; Urology; Testosterone (patch); Prostate-specific antigen; Biochemical recurrence; Randomized controlled trial; Confidence interval; Oncology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001336287,0.001611627,0.002816931,0.0004179613,0.0004990689,0.001239138,0.001191835,0.001431722,0.01267944],"category_scores_gemma":[0.001421242,0.0006582672,0.002598255,0.0005343757,0.001307612,0.0009193736,0.0004069682,0.003678789,0.001361424],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001317465,"about_ca_system_score_gemma":0.001896224,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00438645,"about_ca_topic_score_gemma":0.01102967,"domain_scores_codex":[0.9995048,0.0002410145,0.00002542094,0.0001085006,0.00003394292,0.00008630528],"domain_scores_gemma":[0.9992125,0.0002481236,0.0001723852,0.00006217091,0.0000416195,0.0002632265],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9885796,0.002865736,0.0002176847,0.0003103463,0.0008230301,0.00001759904,0.00002510196,0.0002339959,0.0007873577,0.00007326655,0.0006211413,0.005445155],"study_design_scores_gemma":[0.9816171,0.01681162,0.0006713142,0.00001392315,0.0002844523,0.00001137149,0.00001221963,0.0001859368,0.00008228981,0.00007725386,0.0002250306,0.000007576581],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9815546,0.005351386,0.0008989795,0.001115633,0.001123646,0.004562045,0.002273503,0.0002707384,0.002849447],"genre_scores_gemma":[0.9837632,0.002437927,0.00161969,0.001580319,0.0003785869,0.003767493,0.001611706,0.00005095311,0.004790189],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01267944,"threshold_uncertainty_score":0.04241693,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0251811069725022,"score_gpt":0.3379748630675485,"score_spread":0.3127937560950463,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}